Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CEO Sells $917,112.60 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 119,884 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $7.65, for a total transaction of $917,112.60. Following the sale, the chief executive officer owned 2,992,917 shares of the company’s stock, valued at approximately $22,895,815.05. This represents a 3.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Jeff Shaner also recently made the following trade(s):

• On Thursday, February 19th, Jeff Shaner sold 173,225 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.21, for a total value of $1,248,952.25.
• On Wednesday, February 18th, Jeff Shaner sold 168,800 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.38, for a total value of $1,245,744.00.
• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total transaction of $230,452.45.
• On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total transaction of $226,373.32.
• On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total value of $233,486.44.

Aveanna Healthcare Stock Up 0.3%

Shares of NASDAQ:AVAH traded up $0.02 during trading on Thursday, hitting $7.42. The company’s stock had a trading volume of 3,877,110 shares, compared to its average volume of 938,081. The company has a market capitalization of $1.55 billion, a PE ratio of 20.61 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.67 and a fifty-two week high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The stock’s 50-day moving average price is $8.48 and its two-hundred day moving average price is $8.44.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Barclays boosted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research report on Friday, January 16th. Truist Financial increased their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research report on Friday, November 7th. Raymond James Financial reissued an “outperform” rating and issued a $13.00 price objective on shares of Aveanna Healthcare in a report on Friday, December 5th. Finally, BMO Capital Markets began coverage on Aveanna Healthcare in a report on Thursday, November 13th. They set an “outperform” rating and a $11.00 target price on the stock. Five research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Aveanna Healthcare has an average rating of “Hold” and a consensus price target of $11.06.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors have recently modified their holdings of the business. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare during the second quarter worth about $43,000. MQS Management LLC bought a new position in shares of Aveanna Healthcare during the second quarter valued at approximately $59,000. Belvedere Trading LLC bought a new position in shares of Aveanna Healthcare during the second quarter valued at approximately $62,000. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter worth approximately $64,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Aveanna Healthcare in the 2nd quarter worth approximately $68,000. Institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.